Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Nastro

V.CVM.H

RE:Approval Time

Mayo trial data is desirable though not necessary for the approval process. &...

April 5, 2019

V.CVM.H

RE:RE:RE:Approval period

Yes I believe it was looked at from the start at the FDA had a skeleton staff...

April 5, 2019

V.CVM.H

RE:Approval period

Looney I believe that the average length of time for approval for a de novo...

April 5, 2019

V.CVM.H

RE:Profit Question

Probably an easier question would be what are their revenues expected to be. ...

April 1, 2019

V.CVM.H

RE:Uptrend?

We could really do with a good bit of news now to push this on and take out...

March 24, 2019

V.CVM.H

RE:RE:RE:Further on Canon !

Yes you’re right Looney, slide 20 of the presentation does suggest this...

March 22, 2019

V.CVM.H

RE:Further on Canon !

Yes I realise the potential of the Canon relationship what I hadn’t...

March 22, 2019

V.CVM.H

RE:Canon..........a powerhouse of an enterprise partnership !

That’s an interesting thought as it happens.  I’d never considered the...

March 21, 2019

V.CVM.H

RE:RE:RE:Short Squeeze?

Growth I mean someone is going to have to provide them with lease finance as...

March 21, 2019

V.CVM.H

RE:Short Squeeze?

I’d have to say no.  It was an attempted rally for sure but a genuine...

March 20, 2019

V.CVM.H

RE:RE:RE:RE:RE:Manipulation

I think 38c is probably the ‘pain’ point for the shorts.  I don’t think...

March 19, 2019

V.CVM.H

RE:RE:RE:Manipulation

Don’t think there’s much question it’s being shorted.  We have seen this...

March 18, 2019

V.CVM.H

RE:RE:RE:RE:RE:Medical Conferences

Strange I’d been told the opposite that they wouldn’t say anything until...

March 16, 2019

V.CVM.H

RE:RE:RE:Medical Conferences

Buy I don't think the company would want any of the doctors making any...

March 16, 2019

V.CVM.H

RE:RE:Maybe some more leaked news ?

Those were issued for bringing forward the warrants that were due in October...

March 15, 2019

V.CVM.H

RE:RE:RE:Medical Conferences

It’s not ridiculous at all.  Sure anyone can talk about them and...

March 15, 2019

V.CVM.H

RE:Medical Conferences

That’s my understanding, that none of them can publicly speak about or...

March 14, 2019

V.CVM.H

RE:Somebody was Listening

I didn't really see the problem with it.  Probably just a crack...

March 11, 2019

V.CVM.H

RE:Cost to manufacture

Finance refers to lease finance I think rather than cost of manufacturing...

March 7, 2019

V.CVM.H

RE:RE:RE:RE:RE:RE:Re: Time Line

Wounded my understanding of this is that the submission was actually made on...

March 5, 2019

Prev 1 2 3 4 5 6 7 8 9 10 11 12 Next

Featured Company

BioVaxys Technology Corp.

BioVaxys Technology Corp. C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ... view more »